Assessment Of The Quality Of Life Of Patients With Cardiac Pathology Who Have Experienced Covid-19

Abstract

To date, the global scientific community has not developed uniform approaches to defining the terms “long-Covid” and “post-Covid syndrome,” although these concepts appeared more than a year ago, several months after the start of the pandemic. WHO is also still at the stage of presenting a protocol that is designed to advance issues regarding the formulation of a definition of post-Covid syndrome. Patients with cardiovascular diseases (CVD) constitute a special risk group in the context of the pandemic caused by the COVID-19 coronavirus infection. The spread of COVID-19 poses a particular danger in relation to decompensation of existing chronic diseases, specific damage to the cardiovascular system, especially in the case of severe COVID-19 and a high risk of adverse outcomes in patients with CVD.